(Q37863817)

24 August 2017

1 reference

title

Design of new antihypertensive drugs: Potent and specific inhibitors of angiotensin-converting enzyme (English)

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Cardiology and cardiovascular medicine

1 June 2022

main subject

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

1 June 2022

author name string

D. W. Cushman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214817

1 June 2022

H. S. Cheung

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214817

1 June 2022

E. F. Sabo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214817

1 June 2022

M. A. Ondetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A214817

1 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=214817

1 June 2022

publication date

1 November 1978

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:0033062078900233?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

https://api.elsevier.com/content/article/PII:0033062078900233?httpAccept=text/plain

1 June 2022

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Progress in Cardiovascular Diseases

1 June 2022

published in

1 reference

24 August 2017

21

1 reference

24 August 2017

3

1 reference

24 August 2017

176-182

1 reference

The renin-angiotensin system (first of two parts).

24 August 2017

1

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Angiotensin I converting enzyme

1 June 2022

Renin-Angiotensin System

0 references

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

1 June 2022

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca

1 June 2022

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 June 2022

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

1 June 2022

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881.

1 June 2022

15

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids

1 June 2022

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom

1 June 2022

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

1 June 2022

18

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Carboxypeptidase A: a protein and an enzyme.

1 June 2022

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A

1 June 2022

21

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 June 2022

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

1 June 2022

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme

1 June 2022

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme

1 June 2022

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(78)90023-3

13 January 2023

Identifiers

1 reference

24 August 2017

1 reference